KLOW Blend 80 mg (50 + 10 + 10 + 10) RESEARCH USE ONLY BLACK BOX BIOTECHNOLOGY · KLOW80

KLOW Blend

Also known as: GHK-Cu + TB-500 + BPC-157 + KPV · Four-peptide repair blend
Recovery & Repair Blend In stock Box of 10 vials 4 references

Four-peptide repair and anti-inflammatory co-formulation.

Available sizes

SKUPer vialPack
KLOW80 80 mg (50 + 10 + 10 + 10) 10 vials / box

Order KLOW Blend

Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.

Quote on Telegram Quote on Signal

Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.

An 80 mg vial co-formulating 50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157 and 10 mg KPV. To the triple repair blend it adds KPV, the anti-inflammatory C-terminal tripeptide of α-MSH shown to reduce intestinal inflammation via PepT1 uptake 4. The remaining components are described under BPC-157 1, GHK-Cu 2 and TB-500 3.

At a glance

  • 50 mg GHK-Cu + 10 mg TB-500 + 10 mg BPC-157 + 10 mg KPV
  • 80 mg total per vial
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
Form
Lyophilized powder
Purity
HPLC-verified — Certificate of Analysis available on request
Pack size
Box of 10 vials
Storage
Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.

Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.

  1. Sikiric P, Hahm KB, Blagaic AB, et al. Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future. Gut Liver. 2020;14(2):153-167.
  2. Pickart L, Vasquez-Soltero JM, Margolina A GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.
  3. Goldstein AL, Kleinman HK Advances in the basic and clinical applications of thymosin β4. Expert Opin Biol Ther. 2015;15 Suppl 1:S139-45.
  4. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2007;134(1):166-78.

Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.

Related

Often ordered together

More in Recovery
Quote on Telegram